Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Mixed Despite US-China Trade Deal Optimism

Tue, 08th Jan 2019 08:58

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in Beijing.

The second day of negotiations coincided with an unannounced visit by North Korean leader Kim Jong Un, with some analysts saying China could use Kim's visit as a bargaining chip in the US trade talks.

China's Shanghai Composite index slid 0.26% to 2,526.46 while Hong Kong's Hang Seng index rose 0.15% to 25,875.45.

Japanese shares ended on a positive note after Amazon and Microsoft Corp fueled a second straight session of gains on Wall Street overnight.

The Nikkei average gained 165.07 points or 0.82% to finish at 20,204.04 while the broader Topix index closed 0.39% higher at 1,518.43.

Automaker Honda Motor rallied 3.2% and Toyota rose 1.2% while banks Mitsubishi UFJ Financial, Sumitomo Mitsui Financial and Mizuho Financial rose between 0.3% and 1.3%.

Takeda Pharmaceutical climbed 2.3% after completing its acquisition of Irish drugmaker Shire. Inpex and Japan Petroleum gained around 1% after crude oil prices rose more than 1% overnight.

Olympus Corp jumped 8.4% after Morgan Stanley upgraded the stock's rating to "overweight" from "equal-weight".

Seoul stocks fell as investors monitored the second day of trade talks between China and the US. The benchmark Kospi dropped 11.83 points or 0.58% to 2,025.27. Samsung Electronics lost 1.7% after it partnered with tech giant Apple Inc. to bring iTunes content to Samsung smart televisions.

On the data front, South Korea posted a current account surplus of USD5.06 billion in November, the Bank of Korea said - down from the USD9.19 billion surplus in October. The goods account surplus stood at USD7.97 billion, down from USD11.46 billion in November 2017.

Australian markets closed notably higher amid signs that Beijing and Washington may be inching closer toward a trade deal.

Traders shrugged off weak trade data showing that the country had a seasonally adjusted merchandise trade surplus of AUD1.925 billion in November, shy of expectations for a surplus of AUD2.175 billion and down from AUD2.316 billion in October.

The benchmark S&P/ASX 200 index rose 39.20 points or 0.69% to 5,722.40 while the broader All Ordinaries index ended higher by 38.80 points or 0.68% at 5,783.30.

Banks ANZ, NAB and Westpac rose between 0.9% and 1.2%. Waste management giant Bingo Industries soared 5.7% after it offered to sell its Sydney processing plant to address antitrust concerns related to the planned acquisition of Dial-aDump.

Gold miner Evolution lost 3.4%, St Barbara tumbled 5% and Northern Star Resources declined 2.6% as dovish comments from the Fed boosted investors' appetite for risk.

Sleep device maker ResMed advanced 1.4% after completing the USD225 million acquisition of US-based asthma and pulmonary specialist Propeller Health.

New Zealand shares rose modestly, with the benchmark S&P/NZX 50 index finishing up 15.11 points or 0.17% at 8,821.15.

U.S stocks rose overnight as the US and China resumed talks on their trade war and Federal Reserve Chair Jerome Powell said the central bank would be "flexible" in its approach to monetary policy.

The Dow Jones Industrial Average rose 0.4%, the tech-heavy Nasdaq Composite rallied 1.3% and the S&P 500 climbed 0.7%.

More News
17 Feb 2017 11:03

Britain's FTSE set for week of modest gains, pharmas lead

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 flat, set for third week of gains * Retail sales drop weighs on pound * Copper miners weigh while precious miners edge

Read more
16 Feb 2017 17:05

LONDON MARKET CLOSE: Sterling Rebound, Ex-Divs Send UK Stocks Lower

Read more
16 Feb 2017 15:22

UPDATE 1-Pharma group Shire produces top-of-the-range earnings

* FY earnings rise 12 pct to come in at top of range * Sees strong product sales and earnings growth in 2017 * Shares rise 6 pct (Adds CEO comments, analyst reaction, shares) By Paul Sandle LONDON, Feb 16 (Reuters) - Pharmaceuticals group Shire on Thursday said it was e

Read more
16 Feb 2017 12:30

Shire earnings beat estimates and remains 'extremely optimistic' for 2017

(ShareCast News) - Shire has reported fourth quarter sales and earnings that beat City estimates, with the drugmaker confident of generating strong top- and bottom-line growth in 2017. Revenues for the quarter came in £3.81bn, versus the consensus $3.77bn, while earnings per share of $3.37 beat the

Read more
16 Feb 2017 12:17

Pharma group Shire posts earnings rise at top of guidance

LONDON, Feb 16 (Reuters) - Pharmaceuticals group Shire reported a 12 percent rise in full-year earnings after what it said was a transformational year marked by its largest acquisition to date, adding that it is extremely optimistic on long-term growth prospects. The London-listed company

Read more
7 Feb 2017 20:25

UPDATE 2-FTC sues Shire ViroPharma for fighting generic entry of Vancocin

(Adds that Shire will fight lawsuit, details from complaint) By Diane Bartz WASHINGTON, Feb 7 (Reuters) - The U.S. Federal Trade Commission filed a complaint against Shire ViroPharma on Tuesday, accusing it of hijacking a government channel designed to flag safety issues by using it t

Read more
7 Feb 2017 18:28

FTC sues Shire ViroPharma for fighting generic entry of Vancocin

WASHINGTON, Feb 7 (Reuters) - The U.S. Federal Trade Commission filed a complaint against Shire ViroPharma on Tuesday, accusing it of abusing government processes in order to fend off generic competition to its antibiotic Vancocin HCI, the agency said in a statement. The company filed repea

Read more
1 Feb 2017 15:46

Sector movers: Cyclicals bounce back, Evraz in the lead

(ShareCast News) - There was a clear split in the market on Wednesday as cyclicals bounced back and the more defensive segments of the market were relegated to the bottom of the pile. Thus, shares in Prudential and Aviva were to be seen pacing gains among life insurers as yields on benchmark 10-year

Read more
20 Jan 2017 08:51

Pharma CEOs in Davos put brave face on Trump presidency

By Ben Hirschler DAVOS, Switzerland, Jan 20 (Reuters) - Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market. The following are c

Read more
13 Jan 2017 16:54

Britain's FTSE hits record highs, extends historic winning streak

* FTSE 100 touches new record, sets 14th day of gains * Pharmaceuticals rebound after Trump scare * Housebuilders top the index * ITV buoyed by broker optimism (Adds details and updates prices at close) By Kit Rees and Helen Reid LONDON, Jan 13 (Reuters) - Britain'

Read more
11 Jan 2017 15:27

U.S. says Shire subsidiaries to pay $350 mln to settle false claims act allegations

WASHINGTON, Jan 11 (Reuters) - Shire PLC subsidiaries will pay $350 million to settle U.S. federal and state False Claims Act allegations related to unlawful methods to push "Dermagraft," a treatment for diabetic foot ulcers, the U.S. Justice Department said in a statement on Wednesday. "Th

Read more
22 Dec 2016 06:11

Roche's emicizumab haemophilia drug succeeds in trial

ZURICH, Dec 22 (Reuters) - Roche Holding AG's emicizumab drug for treating haemophilia A met its primary endpoint in a phase III study, the Swiss drugmaker said on Thursday. "The study showed a statistically significant reduction in the number of bleeds over time in people treated with emi

Read more
16 Dec 2016 14:11

FTSE 100 movers: Pharmaceutical stocks lead FTSE's rally

(ShareCast News) - The FTSE 100 rose 0.11% to 7,006.73 points on Friday afternoon with pharmaceutical stocks leading the way. Hikma Pharmaceuticals, Shire and Astrazeneca rallied on a positive read-across following reports Sanofi is in advanced talks to acquire Actelion. The companies are said to b

Read more
16 Dec 2016 09:29

BROKER RATINGS SUMMARY: Shore Upgrades Downtrodden IG And CMC Markets

Read more
7 Dec 2016 17:15

UPDATE 1-Britain's FTSE hits one-month high as banks and miners lead cyclical charge

* FTSE 100 up 1.8 pct * Banks hit 1 1/2-year high * Rio benefits from Credit Suisse upgrade * WPP falls on reported DOJ probe (Recasts, adds detail and updates prices at close) By Kit Rees and Alistair Smout LONDON, Dec 7 (Reuters) - Britain's top share index rose

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.